Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients

Neopterin, a prognostic marker in human malignancies

(2009) Robert Sucher et al.   CANCER LETTERS

Bioavailability of Interferon-beta in patients with multiple sclerosis - fishing for the surrogate

(2009) B. C. Kieseier et al.   EUROPEAN JOURNAL OF NEUROLOGY

Effect of neutralizing antibodies on biomarker responses to interferon beta: The INSIGHT study

(2009) A. R. Pachner et al.   NEUROLOGY

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

(2008) Francesco Matrisciano et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Interferon-beta responders and non-responders. A biological approach

(2008) Antonio Bertolotto et al.   NEUROLOGICAL SCIENCES

Predictive markers for response to interferon therapy in patients with multiple sclerosis

(2008) S. Malucchi et al.   NEUROLOGY